4/A//SEC Filing
DAmour Kevin 4/A
Accession 0001140361-22-009984
CIK 0000748592other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 9:00 PM ET
Size
5.6 KB
Accession
0001140361-22-009984
Insider Transaction Report
Form 4/AAmended
DAmour Kevin
See Remarks
Transactions
- Award
Stock Option (Right to buy)
2022-03-11+138,400→ 138,400 totalExercise: $1.93Exp: 2032-03-11→ Common Stock (138,400 underlying)
Footnotes (1)
- [F1]The options vest and become exercisable in 36 substantially equal monthly installments from the grant date.
Documents
Issuer
Brooklyn ImmunoTherapeutics, Inc.
CIK 0000748592
Entity typeother
Related Parties
1- filerCIK 0001870486
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 9:00 PM ET
- Size
- 5.6 KB